Elevance Health Statistics Share Statistics Elevance Health has 225.18M
shares outstanding. The number of shares has increased by -2.57%
in one year.
Shares Outstanding 225.18M Shares Change (YoY) -2.57% Shares Change (QoQ) -0.62% Owned by Institutions (%) 88.45% Shares Floating 224.79M Failed to Deliver (FTD) Shares 21 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.72M, so 1.21% of the outstanding
shares have been sold short.
Short Interest 2.72M Short % of Shares Out 1.21% Short % of Float 1.21% Short Ratio (days to cover) 1.26
Valuation Ratios The PE ratio is 14.37 and the forward
PE ratio is 9.
Elevance Health's PEG ratio is
8.48.
PE Ratio 14.37 Forward PE 9 PS Ratio 0.49 Forward PS 0.3 PB Ratio 2.08 P/FCF Ratio 18.87 PEG Ratio 8.48
Financial Ratio History Enterprise Valuation Elevance Health has an Enterprise Value (EV) of 108.85B.
EV / Sales 0.62 EV / EBITDA 10.38 EV / EBIT 18.74 EV / FCF 23.91
Financial Position The company has a current ratio of 2.01,
with a Debt / Equity ratio of 0.76.
Current Ratio 2.01 Quick Ratio 2.01 Debt / Equity 0.76 Debt / EBITDA 2.98 Debt / FCF 6.86 Interest Coverage 6.67
Financial Efficiency Return on Equity is 14.47% and Return on Invested Capital is 6.44%.
Return on Equity 14.47% Return on Assets 5.12% Return on Invested Capital 6.44% Revenue Per Employee $1.7M Profits Per Employee $57.39K Employee Count 104,200 Asset Turnover 1.51 Inventory Turnover n/a
Taxes Income Tax 1.93B Effective Tax Rate 24.46%
Stock Price Statistics The stock price has increased by -44.69% in the
last 52 weeks. The beta is 0.59, so Elevance Health's
price volatility has been higher than the market average.
Beta 0.59 52-Week Price Change -44.69% 50-Day Moving Average 341.02 200-Day Moving Average 388.22 Relative Strength Index (RSI) 43.34 Average Volume (20 Days) 2,643,877
Income Statement In the last 12 months, Elevance Health had revenue of 176.81B
and earned 5.98B
in profits. Earnings per share was 25.81.
Revenue 176.81B Gross Profit 176.81B Operating Income 7.9B Net Income 5.98B EBITDA 10.48B EBIT 9.09B Earnings Per Share (EPS) 25.81
Full Income Statement Balance Sheet The company has 8.29B in cash and 31.23B in
debt, giving a net cash position of -22.94B.
Cash & Cash Equivalents 8.29B Total Debt 31.23B Net Cash -22.94B Retained Earnings 33.55B Total Assets 121.94B Working Capital 13.15B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 5.81B
and capital expenditures -1.26B, giving a free cash flow of 4.55B.
Operating Cash Flow 5.81B Capital Expenditures -1.26B Free Cash Flow 4.55B FCF Per Share 19.55
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of 4.47% and 3.38%.
Gross Margin 100% Operating Margin 4.47% Pretax Margin 4.47% Profit Margin 3.38% EBITDA Margin 5.93% EBIT Margin 4.47% FCF Margin 2.57%
Dividends & Yields ELV pays an annual dividend of $8.39,
which amounts to a dividend yield of 2.3%.
Dividend Per Share $8.39 Dividend Yield 2.3% Dividend Growth (YoY) 4.91% Payout Ratio 35.61% Earnings Yield 6.96% FCF Yield 5.3%
Dividend Details Analyst Forecast The average price target for ELV is $417.5,
which is 43.6% higher than the current price. The consensus rating is "Buy".
Price Target $417.5 Price Target Difference 43.6% Analyst Consensus Buy Analyst Count 15
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $185.83 Lynch Upside -36.1% Graham Number 320.18 Graham Upside 10.09%
Stock Splits The last stock split was on Jun 1, 2005. It was a
forward
split with a ratio of 2:1.
Last Split Date Jun 1, 2005 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 2.83 Piotroski F-Score 6
